Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Brandenburgische Tehnische Universitat Cottbus-Senftenberg currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, MCKNIGHT, CIARA A, who is the busiest examiner with 1 pending office action. The prosecution is situated within 1 distinct art unit, which defines the technical environment for the university's current active patent application.
The data shows a concentrated prosecution effort, as the 1 pending office action is the only active matter reported. By working with 1 distinct examiner in 1 distinct art unit, the university faces a singular set of examination criteria. The role of MCKNIGHT, CIARA A is central to the portfolio, as this examiner manages the company's 1 pending office action.
In the field of Biotechnology & Pharmaceuticals, navigating 1 distinct art unit with 1 pending office action suggests a specific research focus. The university's interaction with 1 distinct examiner, MCKNIGHT, CIARA A, represents the entirety of its current patent office engagement. This lack of diversity in examiners or art units means that the prosecution strategy is dependent on the specific feedback received in that single pending action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCKNIGHT, CIARA A | 1 | 61.5% | +40.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288094 | In Vitro Drugs from Prodrugs and Use Thereof | MCKNIGHT, CIARA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18288094 | In Vitro Drugs from Prodrugs and Use Thereof | MCKNIGHT, CIARA A | — |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18288094 | In Vitro Drugs from Prodrugs and Use Thereof | MCKNIGHT, CIARA A | 1656 | §103§112 | Non-Final OA | — | Pending | Oct 24, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBrandenburgische Tehnische Universitat Cottbus-Senftenberg has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ciara A Mcknight has the most, with 1 of Brandenburgische Tehnische Universitat Cottbus-Senftenberg's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
